Galectin Therapeutics Inc. (GALT) Financial Statements (2024 and earlier)

Company Profile

Business Address 4960 PEACHTREE INDUSTRIAL BOULEVARD
NORCROSS, GA 30071
State of Incorp. NV
Fiscal Year End December 31
Industry (SIC) 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete Financial Analysis Financial Benchmarking

Balance Sheet (Statement of Financial Position) (USD)

9/30/2023
MRQ
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments18,592,00039,648,00027,142,00047,480,0008,253,0003,053,000
Cash and cash equivalents18,592,00039,648,00027,142,00047,480,0008,253,0003,053,000
Other undisclosed current assets1,960,0002,172,0002,323,000729,000579,000766,000
Total current assets:20,552,00041,820,00029,465,00048,209,0008,832,0003,819,000
Noncurrent Assets
Other noncurrent assets733,0007,000135,000258,000174,000342,000
Total noncurrent assets:733,0007,000135,000258,000174,000342,000
TOTAL ASSETS:21,285,00041,827,00029,600,00048,467,0009,006,0004,161,000
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities12,948,0009,033,0001,357,0001,727,0002,108,0002,968,000
Interest and dividends payable65,00065,00066,000299,00068,000
Accounts payable3,890,0001,805,0001,292,0001,661,000297,000608,000
Accrued liabilities9,058,0007,163,000  1,512,0002,292,000
Other undisclosed current liabilities 64,000 4,042,0001,093,000  
Total current liabilities:13,012,0009,033,0005,399,0002,820,0002,108,0002,968,000
Noncurrent Liabilities
Liabilities, other than long-term debt705,0001,130,0008,00052,000  
Other liabilities66,000 8,00052,000  
Operating lease, liability66,000   
Derivative instruments and hedges, liabilities573,0001,130,000    
Other undisclosed noncurrent liabilities39,762,00029,048,000    
Total noncurrent liabilities:40,467,00030,178,0008,00052,000  
Total liabilities:53,479,00039,211,0005,407,0002,872,0002,108,0002,968,000
Temporary equity, carrying amount1,723,0001,723,000    
Equity
Equity, attributable to parent, including:(33,917,000)893,00022,470,00043,872,0005,175,000(530,000)
Preferred stock510,000527,000    
Common stock59,00059,00056,00056,00041,00036,000
Additional paid in capital275,081,000271,001,000261,883,000259,673,000194,130,000173,363,000
Accumulated deficit(309,567,000)(270,694,000)(239,996,000)(216,394,000)(196,215,000)(181,168,000)
Other undisclosed equity, attributable to parent   527,000537,0007,219,0007,239,000
Other undisclosed equity   1,723,0001,723,0001,723,0001,723,000
Total equity:(33,917,000)893,00024,193,00045,595,0006,898,0001,193,000
TOTAL LIABILITIES AND EQUITY:21,285,00041,827,00029,600,00048,467,0009,006,0004,161,000

Income Statement (P&L) (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Operating expenses(38,352,000)(30,179,000)(23,444,000)(13,438,000)(13,602,000)(16,247,000)
Operating loss:(38,352,000)(30,179,000)(23,444,000)(13,438,000)(13,602,000)(16,247,000)
Nonoperating income (expense)(424,000)(348,000)(21,000)144,000(298,000)12,000
Investment income, nonoperating609,000141,00066,000231,00038,00024,000
Interest and debt expense(1,033,000)(489,000)(87,000)(87,000)(336,000)(12,000)
Loss from continuing operations:(39,809,000)(31,016,000)(23,552,000)(13,381,000)(14,236,000)(16,247,000)
Loss before gain (loss) on sale of properties:(31,016,000)(23,552,000)(13,381,000)(14,236,000)(16,247,000)
Net loss:(39,809,000)(31,016,000)(23,552,000)(13,381,000)(14,236,000)(16,247,000)
Other undisclosed net income attributable to parent1,033,000489,00087,00087,000336,00012,000
Net loss attributable to parent:(38,776,000)(30,527,000)(23,465,000)(13,294,000)(13,900,000)(16,235,000)
Preferred stock dividends and other adjustments(97,000)(171,000)(137,000)(263,000)(1,147,000)(1,232,000)
Other undisclosed net loss available to common stockholders, basic   (6,622,000)  
Net loss available to common stockholders, diluted:(38,873,000)(30,698,000)(23,602,000)(20,179,000)(15,047,000)(17,467,000)

Comprehensive Income (USD)

9/30/2023
TTM
12/31/2022
12/31/2021
12/31/2020
12/31/2019
12/31/2018
12/31/2017
Net loss:(39,809,000)(31,016,000)(23,552,000)(13,381,000)(14,236,000)(16,247,000)
Comprehensive loss, net of tax, attributable to parent:(39,809,000)(31,016,000)(23,552,000)(13,381,000)(14,236,000)(16,247,000)

Statements Sources

The financial statements are based on the Company's filings with the U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: